tiprankstipranks
Trending News
More News >
Kintor Pharmaceutical Ltd (HK:9939)
:9939
Hong Kong Market

Kintor Pharmaceutical Ltd (9939) Ratios

Compare
3 Followers

Kintor Pharmaceutical Ltd Ratios

HK:9939's free cash flow for Q2 2025 was ¥-2.15. For the 2025 fiscal year, HK:9939's free cash flow was decreased by ¥ and operating cash flow was ¥-13.51. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
0.44 1.03 2.10 4.74 6.94
Quick Ratio
0.42 1.02 2.10 2.84 5.35
Cash Ratio
0.37 0.88 1.98 2.72 4.23
Solvency Ratio
-0.89 -0.62 -2.55 -1.68K 23.42
Operating Cash Flow Ratio
-1.19 -1.19 -1.72 -3.02 -4.78
Short-Term Operating Cash Flow Coverage
-1.95 -1.78 -3.41 >-0.01 -0.14
Net Current Asset Value
¥ -112.54M¥ -49.32M¥ 61.44M¥ 947.92K¥ 1.11M
Leverage Ratios
Debt-to-Assets Ratio
0.22 0.26 0.29 139.35 77.24
Debt-to-Equity Ratio
0.40 0.45 0.55 191.54 96.51
Debt-to-Capital Ratio
0.29 0.31 0.36 0.99 0.99
Long-Term Debt-to-Capital Ratio
0.00 0.06 0.23 0.99 0.99
Financial Leverage Ratio
1.81 1.75 1.90 1.37 1.25
Debt Service Coverage Ratio
-1.58 -1.06 -9.36 -9.68 -83.66
Interest Coverage Ratio
-28.70 -15.58 0.00 0.00 -0.33
Debt to Market Cap
0.07 0.34 0.39 0.08 43.39
Interest Debt Per Share
0.22 0.33 0.59 0.76 455.19
Net Debt to EBITDA
-0.23 0.11 0.18 -0.30 -0.19
Profitability Margins
Gross Profit Margin
-241.14%-94.60%0.00%0.00%100.00%
EBIT Margin
-1449.33%-2919.94%0.00%0.00%-2452750.43%
EBITDA Margin
-1253.26%-2567.40%0.00%0.00%-2418763.69%
Operating Profit Margin
-1648.44%-2891.36%0.00%0.00%-2438.42%
Pretax Profit Margin
-1524.21%-3105.48%0.00%0.00%-2460.04%
Net Profit Margin
-1521.70%-3105.84%0.00%0.00%-2460.04%
Continuous Operations Profit Margin
-1521.70%-3105.84%0.00%0.00%-2460036.22%
Net Income Per EBT
99.84%100.01%99.25%100.11%100.00%
EBT Per EBIT
92.46%107.41%100.91%98.37%100.89%
Return on Assets (ROA)
-46.02%-30.15%-122.04%-46438.24%-40.72%
Return on Equity (ROE)
-70.71%-52.81%-231.56%-63829.36%-50.88%
Return on Capital Employed (ROCE)
-78.48%-41.49%-164.35%-55792.69%-45.16%
Return on Invested Capital (ROIC)
-57.99%-31.33%-139.92%-923.49%-5.38%
Return on Tangible Assets
-72.48%-42.41%-147.28%-52452.61%-45.96%
Earnings Yield
-16.55%-39.57%-166.38%-29.14%-23.59%
Efficiency Ratios
Receivables Turnover
1.68 0.30 0.00 0.00 <0.01
Payables Turnover
0.82 0.25 0.62 0.00 0.00
Inventory Turnover
13.49 4.39 0.00 0.00 0.00
Fixed Asset Turnover
0.07 0.03 0.00 0.00 0.13
Asset Turnover
0.03 <0.01 0.00 0.00 0.02
Working Capital Turnover Ratio
-0.32 0.04 0.00 0.00 0.03
Cash Conversion Cycle
-198.02 -178.40 -590.24 0.00 11.24M
Days of Sales Outstanding
217.40 1.22K 0.00 0.00 11.24M
Days of Inventory Outstanding
27.07 83.09 0.00 0.00 0.00
Days of Payables Outstanding
442.48 1.48K 590.24 0.00 0.00
Operating Cycle
244.46 1.30K 0.00 0.00 11.24M
Cash Flow Ratios
Operating Cash Flow Per Share
-0.39 -0.46 -0.90 >-0.01 -2.95
Free Cash Flow Per Share
-0.40 -0.47 -0.91 >-0.01 -3.16
CapEx Per Share
<0.01 <0.01 <0.01 <0.01 0.21
Free Cash Flow to Operating Cash Flow
1.01 1.01 1.01 1.03 1.07
Dividend Paid and CapEx Coverage Ratio
-79.94 -118.50 -142.34 -34.99 -13.79
Capital Expenditure Coverage Ratio
-79.94 -118.50 -142.34 -34.99 -13.79
Operating Cash Flow Coverage Ratio
-1.94 -1.50 -1.53 >-0.01 >-0.01
Operating Cash Flow to Sales Ratio
-14.31 -39.82 0.00 0.00 -30.71
Free Cash Flow Yield
-14.59%-51.16%-61.21%-0.03%-31.59%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-6.04 -2.53 -0.60 -3.43 -4.24
Price-to-Sales (P/S) Ratio
99.31 78.48 0.00 0.00 104.29
Price-to-Book (P/B) Ratio
5.04 1.33 1.39 2.19K 2.16
Price-to-Free Cash Flow (P/FCF) Ratio
-6.85 -1.95 -1.63 -3.31K -3.17
Price-to-Operating Cash Flow Ratio
-6.42 -1.97 -1.65 -3.41K -3.40
Price-to-Earnings Growth (PEG) Ratio
0.79 0.03 0.25 -0.48 -0.10
Price-to-Fair Value
5.04 1.33 1.39 2.19K 2.16
Enterprise Value Multiple
-8.16 -2.94 -0.42 -3.72 -0.20
Enterprise Value
1.21B 377.99M 446.02M 3.56B 162.37M
EV to EBITDA
-8.16 -2.94 -0.42 -3.72 -0.20
EV to Sales
102.22 75.60 0.00 0.00 4.74K
EV to Free Cash Flow
-7.06 -1.88 -1.14 -3.60K -144.00
EV to Operating Cash Flow
-7.14 -1.90 -1.15 -3.70K -154.44
Tangible Book Value Per Share
0.17 0.34 0.72 <0.01 3.98
Shareholders’ Equity Per Share
0.50 0.68 1.07 <0.01 4.64
Tax and Other Ratios
Effective Tax Rate
<0.01 >-0.01 >-0.01 >-0.01 0.27
Revenue Per Share
0.03 0.01 0.00 0.00 0.10
Net Income Per Share
-0.42 -0.36 -2.47 -2.53 -2.36
Tax Burden
1.00 1.00 0.99 1.00 1.00
Interest Burden
1.05 1.06 1.00 0.00 <0.01
Research & Development to Revenue
6.65 15.63 0.00 0.00 22.43
SG&A to Revenue
0.00 12.37 0.00 0.00 2.98
Stock-Based Compensation to Revenue
0.00 -1.85 0.00 0.00 1.09K
Income Quality
0.94 1.28 0.36 1.01 1.25
Currency in CNY